Home>
US Stocks>
Iovance Biotherapeutics

Iovance Biotherapeutics share price today

(IOVA)

Iovance Biotherapeutics share price is $8.58 & -₹8.58 as on 12 Dec 2024, 2.30 'hrs' IST

$8.58

▲

-0.01

(-0.12%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Iovance Biotherapeutics share price in Dollar and Rupees. Guide to invest in Iovance Biotherapeutics from India. Also see the sentimental analysis on Indian investors investing in Iovance Biotherapeutics. Get details on the Indian mutual funds that are investing in Iovance Biotherapeutics. Get Analyst recommendations and forecasts along with all the Iovance Biotherapeutics's financials.

Iovance Biotherapeutics share price movements

$8.39
$8.74
$8.58
2.21%
Downside
Day's Volatility :4.0%
Upside
1.83%
$6.00
$18.33
$8.58
30.07%
Downside
52 Weeks Volatility :67.27%
Upside
53.19%

Iovance Biotherapeutics Returns

Period	Iovance Biotherapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-9.3%	-8.8%	0.0%
6 Months	1.78%	-2.7%	0.0%
1 Year	16.73%	6.5%	0.0%
3 Years	-52.88%	5.6%	-20.0%

Iovance Biotherapeutics Key Statistics

in dollars & INR

Previous Close	$8.59
Open	$8.65
Today's High	$8.74
Today's Low	$8.39
Market Capitalization	$2.7B
Today's Volume	$4.2M
52 Week High	$18.33
52 Week Low	$6.0
Revenue TTM	$90.9M
EBITDA	$-408.3M
Earnings Per Share (EPS)	$-1.48
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-56.65%

How to invest in Iovance Biotherapeutics from India?

It is very easy for Indian residents to invest directly in Iovance Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iovance Biotherapeutics stock in both rupees (INR) and dollars (USD). Search for Iovance Biotherapeutics or IOVA on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iovance Biotherapeutics or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iovance Biotherapeutics shares which would translate to -0.001 fractional shares of Iovance Biotherapeutics as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Iovance Biotherapeutics

-13.56%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Investment in Iovance Biotherapeutics from India has reduced in the last 30 days as on Dec 12, 2024. -13.56% less purchase transactions for Iovance Biotherapeutics in the last 30 days versus the previous period.

-24%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Iovance Biotherapeutics on INDmoney from India has reduced in the last 30 days as on Dec 12, 2024. -24% less investors are searching Iovance Biotherapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Iovance Biotherapeutics

Vanguard Group Inc
8.96%
Perceptive Advisors LLC
8.73%
Mhr Fund Management Llc
7.87%
BlackRock Inc
6.96%
State Street Corp
4.33%
Soleus Capital Management, L.P.
2.80%

Analyst Recommendation on Iovance Biotherapeutics

Buy

90%Buy

10%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Iovance Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Iovance Biotherapeutics

What analysts predicted

Upside of 177.03%

Current:

$8.58

Target:

$23.77

Insights on Iovance Biotherapeutics

Price Movement
In the last 1 month, IOVA stock has moved down by -11.5%
IOVA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 46.2% return, outperforming this stock by 11.9%
IOVA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.4% return, outperforming this stock by 99.9%
Price to Sales
ForIOVA every $1 of sales, investors are willing to pay $26.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $15.4 for every $1 of sales.

Iovance Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Iovance Biotherapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Iovance Biotherapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iovance Biotherapeutics, Inc.	-11.46%	1.78%	16.73%	-52.88%	-68.8%
Regeneron Pharmaceuticals, Inc.	-5.85%	-24.7%	-11.77%	17.09%	105.58%
Biontech Se	12.25%	24.31%	22.8%	-57.11%	240.97%
Alnylam Pharmaceuticals, Inc.	-5.5%	58.79%	40.79%	36.33%	111.58%
Vertex Pharmaceuticals Incorporated	-4.43%	-2.24%	15.61%	124.98%	113.34%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iovance Biotherapeutics, Inc.	NA	NA	0.0	-1.29	-0.57	-0.29	NA	2.54
Regeneron Pharmaceuticals, Inc.	19.27	19.27	1.17	45.03	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.24	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iovance Biotherapeutics, Inc.	Buy	$2.7B	-68.8%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$86.6B	105.58%	19.27	33.61%
Biontech Se	Buy	$28.0B	240.97%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	111.58%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$122.1B	113.34%	32.84	-4.51%

Iovance Biotherapeutics Dividend announcements

Iovance Biotherapeutics Earnings
Iovance Biotherapeutics’s price-to-earnings ratio stands at None
Read More

About Iovance Biotherapeutics

iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr. steven a. rosenberg at the national cancer institute (nci). in phase 2 clinical trials conducted at the nci, 56% and 24% of patients treated with this technology were reported by nci to have achieved objective and complete response criteria, respectively. our lead product candidate is an autologous, ready-to-infuse cell therapy, that has demonstrated distinctive efficacy in the treatment of metastatic melanoma. in addition to metastatic melanoma, carcinoma of the head and neck and cervical cancer our til therapy technology is potentially applicable to many other tumor types, including ovarian, breast, bladder, colorectal and other cancers. as we continue advancing our current clinical programs through the introduction of manufacturing and logistical

Organization	Iovance Biotherapeutics
Employees	557
CEO	Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Industry	Health Technology

Management People of Iovance Biotherapeutics

Name	Title
Dr. Frederick G. Vogt Esq., J.D., Ph.D.	Interim CEO, President, General Counsel, Corporate Secretary & Director
Mr. Jean-Marc Bellemin M.B.A.	CFO, Principal Accounting Officer & Treasurer
Dr. Igor P. Bilinsky Ph.D.	Chief Operating Officer
Dr. Friedrich Graf Finckenstein M.D.	Chief Medical Officer
Ms. Sara Pellegrino	Vice President of Investor Relations & Public Relations
Ms. Tracy Winton	Executive Vice President of Human Resources
Mr. Howard B. Johnson M.B.A.	Chief Business Officer
Dr. Raj K. Puri M.D., Ph.D.	Chief Regulatory Officer
Mr. Brian Shew M.B.A.	Senior VP & Head of Digital and Information Technology
Mr. Kevin Smyth	Executive Vice President of Quality

Important FAQs about investing in Iovance Biotherapeutics from India :

What is Iovance Biotherapeutics share price today?

Iovance Biotherapeutics (IOVA) share price today is $8.58.

Can Indians buy Iovance Biotherapeutics shares?

Yes, Indians can invest in the Iovance Biotherapeutics (IOVA) from India.

With INDmoney, you can buy Iovance Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Iovance Biotherapeutics at zero transaction cost.

How can I buy Iovance Biotherapeutics shares from India?

It is very easy to buy Iovance Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iovance Biotherapeutics be purchased?

Yes, you can buy fractional shares of Iovance Biotherapeutics with INDmoney app.

What are the documents required to start investing in Iovance Biotherapeutics stocks?

To start investing in Iovance Biotherapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.